Anzeige
Mehr »
Login
Donnerstag, 28.03.2024 Börsentäglich über 12.000 News von 687 internationalen Medien
Spezial am Donnerstag: Rallye II. - Neuer Anstoß, News und was die Börsencommunity jetzt nicht verpassen will…
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
PR Newswire
415 Leser
Artikel bewerten:
(1)

Optomed launches Aurora IQ, handheld fundus camera with integrated artificial intelligence for faster eye screening

HELSINKI, Nov. 26, 2020 /PRNewswire/ -- Optomed launches its latest camera product, Aurora IQ in a global launch webinar on 26th of November. The camera has new image quality and usability features and it seamlessly integrates artificial intelligence for faster image analysis, so that the AI result can be read from the camera screen in seconds. This is a significant product for our customers and partners, as it speeds up the eye screening process and reduces costs, and therefore improves access to eye screenings globally. The Aurora IQ is CE-approved and ready for commercialization, so sales and marketing activities can start immediately after the webinar.

Laura Piila, Vice President Devices at Optomed, comments:

"Aurora IQ is our most important product launch for the near future, and we will focus majority of our sales and marketing efforts to the commercialization of this AI-integrated camera globally. I am extremely proud of the pioneering work we have done within the handheld fundus camera technology and market creation. Also, the strong partnerships we have created with various AI companies, research teams and universities, have enabled us to bring artificial intelligence analysis to our customers and supporting them in improving access to eye screenings and preventing blindness."

Further enquiries:

Laura Piila
Vice President Devices
Optomed Plc
+358 40 588 1187
laura.piila@optomed.com

Optomed in Brief

Optomed is a Finnish medical technology company and one of the leading providers of handheld fundus cameras. Optomed combines handheld cameras with software and artificial intelligence with the aim to transform the diagnostic process of blinding eye-diseases such as rapidly increasing diabetic retinopathy. In its business Optomed focuses on eye-screening devices and software solutions related R&D in Finland and sales through different channels in over 60 countries. The company has an extensive portfolio of 56 international patents protecting the technology. In 2019, Optomed's revenue reached EUR 15 million and the company employed 108 professionals.

This information was brought to you by Cision http://news.cision.com

https://news.cision.com/optomed-oyj/r/optomed-launches-aurora-iq--handheld-fundus-camera-with-integrated-artificial-intelligence-for-faste,c3243662

Großer Dividenden-Report 2024 von Dr. Dennis Riedl
Der kostenlose Dividenden-Report zeigt ganz genau, wo Sie in diesem Jahr zuschlagen können. Das sind die Favoriten von Börsenprofi Dr. Dennis Riedl
Jetzt hier klicken
© 2020 PR Newswire
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.